Ruth Oren Hommonai
Chief Executive Officer at INTER GAMMA INVESTMENT COMPANY LTD
Profile
Ruth Oren Hommonai is currently the Chief Executive Officer at Inter-Gamma Investment Ltd.
She previously worked as the Director of the Legal Department at Dexcel Pharma Technologies Ltd.
Ms. Oren Hommonai graduated from Tel-Aviv University and holds an MBA from The Interdisciplinary Center Herzliya.
Ruth Oren Hommonai active positions
| Companies | Position | Start |
|---|---|---|
| INTER GAMMA INVESTMENT COMPANY LTD | Chief Executive Officer | 2013-12-31 |
Former positions of Ruth Oren Hommonai
| Companies | Position | End |
|---|---|---|
Dexcel Pharma Technologies Ltd.
 Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | General Counsel | - |
Training of Ruth Oren Hommonai
| Tel-Aviv University | Graduate Degree |
| The Interdisciplinary Center Herzliya | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| INTER GAMMA INVESTMENT COMPANY LTD | Finance |
| Private companies | 1 |
|---|---|
Dexcel Pharma Technologies Ltd.
Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | Health Technology |
- Stock Market
- Insiders
- Ruth Oren Hommonai
